Equities

Genprex Inc

Genprex Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)0.382
  • Today's Change-0.008 / -2.05%
  • Shares traded258.01k
  • 1 Year change-97.87%
  • Beta-0.5665
Data delayed at least 15 minutes, as of Sep 20 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Directors & dealings data is unavailable for this security.

Directors & Officers

Click or tap a row for biographies

NameTitleCompensationAgeOfficer since
Jose Moreno ToscanoIndependent Chairman of the Board--512020
Ryan ConferPresident, Chief Executive Officer, Chief Financial Officer, Director--422011
Mark BergerChief Medical Officer484.16kUSD692021
Brent LongneckerIndependent Director--672020
William WilsonIndependent Director--742020

Director dealings

Dealing dateName / TitleSharesPer share
(USD)
Share /
Per share (USD)
Deal size
(USD)

Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.